Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
NCT07111325

Safety and Preliminary Efficacy of iEVs Injection in Treating Lateral Epicondylitis of Humerus

Led by Shanghai 6th People's Hospital · Updated on 2025-08-08

24

Participants Needed

1

Research Sites

130 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Evaluate the safety and preliminary efficacy of human induced pluripotent stem cell-derived extracellular vesicle (iEV) injection in the treatment of lateral epicondylitis of the humerus.

CONDITIONS

Official Title

Safety and Preliminary Efficacy of iEVs Injection in Treating Lateral Epicondylitis of Humerus

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with lateral epicondylitis by clinical symptom examination and MRI or ultrasound, without obvious tendon tear
  • Unilateral lateral elbow pain lasting for more than 12 weeks
  • Pain provoked by at least 2 methods with a pain VAS score exceeding 3: maximum grip strength, palpation of lateral epicondyle and surrounding area, resisted dorsiflexion of wrist or middle finger, or stretching of forearm extensor muscles under pain-free grip
  • Received physical therapy or non-steroidal anti-inflammatory drug treatment with poor efficacy
  • Individuals with independent behavioral capacity who have signed informed consent themselves
Not Eligible

You will not qualify if you...

  • Ipsilateral muscle pain caused by other reasons in the past 6 months
  • Presence of ipsilateral neurogenic, inflammatory, or systemic joint diseases
  • History of lateral epicondylitis surgery in the past 6 months
  • Deemed unsuitable for trial participation due to other conditions by the researcher
  • MRI showing injury involving lateral collateral ligament with concurrent cartilage damage

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Shanghai Sixth hospital

Shanghai, Shanghai Municipality, China, 200000

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here